Affluent Medical SA (EPA:AFME)
France · Delayed Price · Currency is EUR 1.970
-0.030 (-1.50%)
At close: Jan 30, 2026
Affluent Medical Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 4.12 | 4.12 | - | - | - | - |
Other Revenue | 1.15 | 1.23 | 1.22 | 1.34 | 1.45 | 0.82 |
| 5.27 | 5.35 | 1.22 | 1.34 | 1.45 | 0.82 | |
Revenue Growth (YoY) | 306.64% | 337.09% | -8.59% | -7.72% | 76.09% | -42.34% |
Cost of Revenue | 4.35 | 3.59 | 2.42 | 2.68 | 2.74 | 3.26 |
Gross Profit | 0.92 | 1.76 | -1.2 | -1.34 | -1.29 | -2.44 |
Selling, General & Admin | 13.22 | 13.8 | 11.87 | 10.55 | 9.68 | 8.11 |
Other Operating Expenses | 0.25 | 0.22 | -0.08 | 0.06 | -0.04 | 0.02 |
Operating Expenses | 15.84 | 16.41 | 14.2 | 13.05 | 12.06 | 10.03 |
Operating Income | -14.92 | -14.65 | -15.4 | -14.39 | -13.35 | -12.47 |
Interest Expense | -0.46 | -0.5 | -0.39 | -1.06 | -3.04 | -2.13 |
Interest & Investment Income | 0.12 | 0.1 | 0 | - | - | - |
Earnings From Equity Investments | - | - | - | - | -0.01 | -0.4 |
Currency Exchange Gain (Loss) | -0.01 | - | - | - | - | 0 |
Other Non Operating Income (Expenses) | 0.44 | 0.17 | -0.01 | -0.05 | 1.03 | 0.59 |
EBT Excluding Unusual Items | -14.84 | -14.89 | -15.8 | -15.5 | -15.38 | -14.4 |
Gain (Loss) on Sale of Assets | - | - | - | -0.02 | 0.02 | - |
Legal Settlements | - | 0.01 | - | 0.12 | 0.1 | -0.13 |
Pretax Income | -14.84 | -14.88 | -15.8 | -15.4 | -15.26 | -14.53 |
Income Tax Expense | -0.1 | -0.14 | -0.15 | -0.17 | -0.44 | -0.21 |
Net Income | -14.74 | -14.74 | -15.65 | -15.23 | -14.82 | -14.32 |
Net Income to Common | -14.74 | -14.74 | -15.65 | -15.23 | -14.82 | -14.32 |
Shares Outstanding (Basic) | 39 | 36 | 29 | 19 | 17 | 13 |
Shares Outstanding (Diluted) | 39 | 36 | 29 | 19 | 17 | 13 |
Shares Change (YoY) | 22.97% | 23.39% | 54.03% | 11.93% | 26.30% | 12.27% |
EPS (Basic) | -0.38 | -0.41 | -0.54 | -0.81 | -0.88 | -1.07 |
EPS (Diluted) | -0.38 | -0.41 | -0.54 | -0.81 | -0.88 | -1.07 |
Free Cash Flow | -14.6 | -11.47 | -12.23 | -11.23 | -12.7 | -9.24 |
Free Cash Flow Per Share | -0.37 | -0.32 | -0.42 | -0.59 | -0.75 | -0.69 |
Gross Margin | 17.39% | 32.97% | -98.04% | -99.85% | -88.90% | -295.63% |
Operating Margin | -283.38% | -273.83% | -1258.01% | -1074.61% | -920.12% | -1513.23% |
Profit Margin | -279.97% | -275.50% | -1278.84% | -1137.19% | -1021.36% | -1737.74% |
Free Cash Flow Margin | -277.27% | -214.41% | -998.77% | -838.46% | -875.12% | -1121.36% |
EBITDA | -12.89 | -12.61 | -13.35 | -12.33 | -11.26 | -10.82 |
EBITDA Margin | -244.76% | -235.78% | - | - | - | - |
D&A For EBITDA | 2.03 | 2.04 | 2.05 | 2.06 | 2.09 | 1.65 |
EBIT | -14.92 | -14.65 | -15.4 | -14.39 | -13.35 | -12.47 |
EBIT Margin | -283.38% | -273.83% | - | - | - | - |
Advertising Expenses | - | 0.1 | 0.08 | 0.08 | 0.05 | 0.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.